Leading vascular intervention device company, MicroPort Medical, listed on the Hong Kong Stock Exchange | Chenkun Family

2022-12-23

On December 23, "Yeju Medical," a portfolio company backed by Share Investment, a sub-fund invested in by the flagship fund managed by Yuanhe Chukun, was listed on the Hong Kong Stock Exchange under the stock code: 6929.HK.

China's first publicly listed ALD equipment company—Weidao Nanomaterials Debuts on the STAR Market | Chenkun Family

2022-12-23

On December 23, "Weidao Nano," a portfolio company invested in by Junlian Capital—its sub-fund backed by the mother fund managed by Yuanhe Chencun—was listed on the STAR Market, with stock code: 688147.

Leading photovoltaic testing company OpTech lists on the Beijing Stock Exchange | Chenkun Family

2022-12-12

On December 12, "Optai," an investee company of Xingfu Capital— a sub-fund backed by the master fund managed by Yuanhe Chencun—was listed on the Beijing Stock Exchange, with stock code: 836414.

Leading stapler manufacturer, Dongxing Medical, listed on the ChiNext Board | Chenkun Family

2022-11-30

On November 30, "Dongxing Medical," an investee company of Jifeng Capital—a sub-fund backed by the mother fund managed by Yuanhe Chencun—was listed on the ChiNext Board, with stock code: 301290.

China's No. 1 newcomer to the lodging economy—Atour Group—debuts on Nasdaq | Chenkun Family

2022-11-11

On November 11, "Atour Group," a portfolio company of Junlian Capital—a sub-fund invested in by the master fund managed by Yuanhe Chencun—successfully listed on the NASDAQ in the U.S., with the stock symbol: ATAT.

The first recombinant collagen stock—Giant Bio—lists on the Hong Kong Stock Exchange | Chenkun Family

2022-11-04

On November 4, "Juzi Bio," a portfolio company of HeYi ChenKun-managed fund-of-funds and invested in by Black Ant Capital, officially listed on the Hong Kong Stock Exchange under the stock code: 2367.HK.